Vnitr Lek 2006, 52(12):1146-1147

Alogenní transplantace krvetvorných buněk u nemocných s chronickou myeloidní leukemií - editorial

J. Voglová
Oddělení klinické hematologie II. interní kliniky Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc.

Received: August 11, 2006; Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Voglová J. Alogenní transplantace krvetvorných buněk u nemocných s chronickou myeloidní leukemií - editorial. Vnitr Lek. 2006;52(12):1146-1147.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fefer A, Cheever MA, Thomas ED at al. Disapperarance of Ph1-positive cells in four patients after chemotherapy, irradiation and marrow transplantation from an identical twin. N Eng J Med 1979; 300: 333-337. Go to original source... Go to PubMed...
    2. Gratwohl A, Brand R, Apperley J et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, tong-term data and current results. An Analysis by the Chronic Leukemia Working Party of the European Group of Blood and Marrow Transplantation (EBMT). Haematologica 2006; 91: 513-521. Go to PubMed...
    3. Simonsson B. On Behalf of the IRIS Study Group: Beneficial effects of cytogenetic and molecular response on long-term outcome in patients with newly diagnosed chronic myeloid leukemia in chronic phase treated with imatinib. Update from the IRIS study. Blood 2005; 106: 52a. Go to original source...
    4. Deninger M, Schleunign M, Greinix H et al. The effect of prior exposure to imatinib on transplant-related mortality. Haematologica 2006; 91: 452-459. Go to PubMed...
    5. Baccarani M, Saglio G, Goldman JM et al. Evolving concepts in the management of chronic myeloid leukemia. Rocommedations from an expert panel on behalf of the European LeukemiNet. Blood 2006; 108: 1809-1820. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.